Table 2 Association (adjusted odds ratio, OR, with 95% confidence interval, CI) of low avidity HPV16 antibodies with increased risk of being seropositive for other HPV types among Finnish and Ugandan women.
Population | Seropositivity | OR1(95% CI) | OR2(95% CI) | OR3(95% CI) |
|---|---|---|---|---|
Finland (n = 248) | HPV16 only | 1 | 1 | 1 |
HPV16 + 6 or 11 | 1.1 (0.4-2.8) | 1.9 (0.6-6.1) | 0.8 (0.1-6.8) | |
HPV + 31 or 33 | 0.3 (0.1-1.0) | 0.3 (0.1-1.3) | 0.8 (0.0-1.0) | |
HPV + 18 or 45 | 0.7 (0.2-1.8) | 0.5 (0.1-2.0) | 0.3 (0.2-3.8) | |
Uganda (n = 117) | HPV16 only | 1 | 1 | 1 |
HPV16 + 6 or 11 | 3.5 (1.3-9.7) | 3.0 (1.1-8.5) | 2.9 (1.0*-8.4) | |
HPV + 31 or 33 | 0.8 (0.2-2.9) | 0.7 (0.2-2.5) | 0.6 (0.2-2.3) | |
HPV + 18 or 45 | 0.6 (0.1-3.0) | 0.5 (0.1-2.9) | 0.5 (1.0-2.8) |